Tilray consolidates Canadian production as cannabis sales decline
Tilray Brands expects $10 million in annualized savings from consolidating Canadian cultivation and pre-roll operations.
News November 2Tilray Brands expects $10 million in annualized savings from consolidating Canadian cultivation and pre-roll operations.
News November 2Canopy Growth will supply four Canadian-grown flower strains to the UK through GROW Group, extending its European medical…
News September 22Tilray raises global medical cannabis capacity, expanding cultivation in Quebec and Portugal to meet rising demand.
News August 21Tilray CEO Irwin Simon sees a future where cannabis is treated like other medicine: prescribed by doctors and…
News May 7The deal includes BrewDog’s global brand, intellectual property, brewing operations in and 11 brewpubs across the U.K. and…
News March 2With President Donald Trump’s executive order to reschedule marijuana, operators in the $32 billion cannabis industry are anticipating…
News December 23Tilray Medical is leaving New Zealand's medical cannabis market to focus on its MMJ operations in Australia.
News April 25Aphria RX, a subsidiary of Tilray Brands, launched the first commercial medical cannabis flower grown at its facility…
News November 14Days after exercising an option to acquire a U.S.-based marijuana multistate operator, onetime billion-dollar cannabis giant Canopy Growth…
News June 7